BIO.News Newsletter

While waiting to see who will win Speaker of the House, you can apply for the Start-Up Stadium at this year’s BIO International Convention, and check out a new down coat made with sugarcane and biotechnology. (540 words, 2 minutes, 42 seconds)

Happy New Year! As the 118th Congress begins, catch up on the news you missed during the break, from the approval of key ag trade officials to the advancement of new biotech breakthroughs. (611 words, 3 minutes, 3 seconds)

It’s our last issue of Good Day BIO for the year, so we’re giving you some holiday reading: our most popular stories on Bio.News and a few exclusives you need to read before the new year, plus the latest on the TRIPS waiver and government funding. (685 words, 3 minutes, 25 seconds)Good Day BIO will be on break for the holidays, returning Tuesday, January 3. In the meantime, keep an eye on Bio.News to stay up to date. We hope you have a wonderful holiday and look forward to seeing you in 2023!

BIO experts have been analyzing the 4,155-page omnibus spending bill since it was delivered around 2 a.m. yesterday. There are key provisions related to biopharma, agriculture, and environment. (805 words, 4 minutes, 1 second)

The government wants you to weigh in on how to streamline biotech regulation and the value of the bioeconomy—we tell you how. Plus, BIO’s been working with international partners on global regulatory harmonization of pharmaceutical regulations, which could help us prepare for the next pandemic. (613 words, 3 minutes, 3 seconds)

We’re officially in the home stretch of the year. Today, we have news on Mexico’s proposed corn ban, a recap of BIO’s event during the U.S.-Africa Summit and what it means for cancer in Africa, and a lot more health news. (791 words, 3 minutes, 57 seconds)

For your weekend reading, we have our 2022 midterms recap: what happened, why it matters, and what the results mean for biotech innovation and patients. Plus, ahead of Agriculture Secretary Vilsack’s meeting with Mexico today, bipartisan Senators are calling for the U.S. to take action on the proposed corn ban. (740 words, 3 minutes, 42 seconds)

With appropriations negotiations underway on Capitol Hill, we look at what some members of Congress want the package to say about genome editing for food. Plus,the FDA cut back on use of Accelerated Approval in 2022—a very unwelcome holiday surprise for patients.  (634 words, 3 minutes, 10 seconds)

Hard to believe the first COVID vaccines were administered in the U.S. two years ago today—here’s more on the impact on lives and money saved, and future R&D. Plus, President Biden’s hosting the U.S.-Africa Leaders Summit and today will highlight the role for biotech. (501 words, 2 minutes, 30 seconds)

Recent data provides more evidence of the need for equity and inclusion in clinical trials and drug development—here’s what we’re doing about it. And while we know the lame duck is busy, the Senate should add two key agriculture nominations to the agenda. (551 words, 2 minutes, 45 seconds)